This latter study proved the ability of an HERV-H-derived peptide to increase the production of CCL19, and its role as a chemo attractive factor in recruiting an elevated number of immunosuppressive immune cells in HERV-H+ CCL19+ colon cancer tissues. The gene discussed is CCL19; the disease is malignant colon neoplasm.